Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lone Jeppesen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Lipid Research|March 5, 2004
Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profilesKlaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Selective PPAR agonists for the treatment of type 2 diabetesJan O Nehlin, John P Mogensen, Ingrid Petterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships of dimeric PPAR agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|October 31, 2003
Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivoPer Sauerberg, Paul S Bury, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural templateJohn P Mogensen, Lone Jeppesen, Paul S Bury, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|September 20, 2002
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1BHenrik Sune Andersen, Ole H Olsen, Lars F Iversen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Lipid Research|March 5, 2004
Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profilesKlaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Selective PPAR agonists for the treatment of type 2 diabetesJan O Nehlin, John P Mogensen, Ingrid Petterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships of dimeric PPAR agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Design of potent PPARalpha agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|October 31, 2003
Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivoPer Sauerberg, Paul S Bury, John P Mogensen, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of novel PPARalpha/gamma/delta triple activators using a known PPARalpha/gamma dual activator as structural templateJohn P Mogensen, Lone Jeppesen, Paul S Bury, et al.
Journal of Medicinal Chemistry|March 9, 2007
Identification and synthesis of a novel selective partial PPARdelta agonist with full efficacy on lipid metabolism in vitro and in vivoPer Sauerberg, Grith S Olsen, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|September 20, 2002
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1BHenrik Sune Andersen, Ole H Olsen, Lars F Iversen, et al.
Pageof 1